Multiple Sclerosis. G35
Conditions
Interventions
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Diagnosis of multiple sclerosis (MS) Suffering from fatigue Satisfaction for participation in the research project Living in Mashhad
Exclusion criteria
Exclusion criteria: Willingness to withdraw from the study Exacerbation of manifestations of MS after each IV administration Under treatment for depression
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fatigue score. Timepoint: At baseline and after 12 weeks. Method of measurement: Using Modified Fatigue Impact Scale (MFIS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: At baseline and after 12 weeks. Method of measurement: Using European Quality of Life 5 Dimensions 3 Level Version (EQ-5D-3L).;Depression and anxiety. Timepoint: At baseline and after 12 weeks. Method of measurement: Using Hospital Anxiety and Depression Scale (HADS).;Ability to walk. Timepoint: At baseline and after 12 weeks. Method of measurement: Multiple Sclerosis Walking Scale-12 (MSWS-12).;Inflammatory markers including C-reactive protein, gene expression of TNFa, IFN?, IL10, IL16, IL17). Timepoint: At baseline and after 12 weeks. Method of measurement: Blood Sample. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Emadzadeh
Mashhad University of Medical Sciences
Outcome results
None listed